Biomea Fusion, Inc. (BMEA)
0.8399
+0.01
(+0.71%)
USD |
NASDAQ |
Oct 15, 10:03
Biomea Fusion Price : 0.8399 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 0.9987 | 0.9987 | 0.8005 | 0.834 | 11.71M |
| Oct 13, 2026 | 1.435 | 1.437 | 1.23 | 1.26 | 8.316M |
| Oct 12, 2026 | 1.44 | 1.460 | 1.36 | 1.36 | 5.369M |
| Oct 09, 2026 | 1.38 | 1.45 | 1.38 | 1.42 | 1.171M |
| Oct 08, 2026 | 1.32 | 1.38 | 1.30 | 1.37 | 1.707M |
| Oct 07, 2026 | 1.27 | 1.34 | 1.25 | 1.32 | 836126.0 |
| Oct 06, 2026 | 1.28 | 1.31 | 1.24 | 1.25 | 797006.0 |
| Oct 05, 2026 | 1.27 | 1.31 | 1.22 | 1.30 | 1.044M |
| Oct 02, 2026 | 1.30 | 1.305 | 1.26 | 1.27 | 844359.0 |
| Oct 01, 2026 | 1.32 | 1.36 | 1.30 | 1.30 | 1.070M |
| Sep 30, 2026 | 1.29 | 1.37 | 1.26 | 1.33 | 1.453M |
| Sep 29, 2026 | 1.28 | 1.300 | 1.25 | 1.26 | 1.556M |
| Sep 28, 2026 | 1.32 | 1.365 | 1.27 | 1.29 | 1.457M |
| Sep 25, 2026 | 1.49 | 1.49 | 1.303 | 1.32 | 3.083M |
| Sep 24, 2026 | 1.46 | 1.50 | 1.39 | 1.49 | 2.185M |
| Sep 23, 2026 | 1.70 | 1.720 | 1.35 | 1.44 | 9.301M |
| Sep 22, 2026 | 1.71 | 1.78 | 1.66 | 1.70 | 2.337M |
| Sep 21, 2026 | 1.84 | 1.85 | 1.675 | 1.71 | 1.786M |
| Sep 18, 2026 | 1.79 | 1.93 | 1.770 | 1.83 | 1.631M |
| Sep 17, 2026 | 1.78 | 1.835 | 1.72 | 1.79 | 1.374M |
| Sep 16, 2026 | 1.80 | 1.835 | 1.705 | 1.74 | 1.596M |
| Sep 15, 2026 | 1.79 | 1.815 | 1.660 | 1.80 | 1.344M |
| Sep 14, 2026 | 1.715 | 1.79 | 1.66 | 1.78 | 1.552M |
| Sep 11, 2026 | 1.75 | 1.78 | 1.70 | 1.74 | 1.481M |
| Sep 10, 2026 | 1.83 | 1.84 | 1.68 | 1.70 | 2.501M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 7.03 |
| Compass Therapeutics, Inc. | 0.8805 |
| ACADIA Pharmaceuticals, Inc. | 19.85 |
| Alnylam Pharmaceuticals, Inc. | 231.75 |
| Anika Therapeutics, Inc. | 20.69 |
Price Related Metrics
| Price to Book Value | 5.016 |
| Earnings Yield | -59.19% |
| Market Cap | 60.88M |